DIABETIC MACROANGIOPATHY

This adverse event was reported 33 times

These drugs are most commonly taken by patients reporting DIABETIC MACROANGIOPATHY:

# Drug Count
0 BASILIXIMAB 15
1 MIDAZOLAM HYDROCHLORIDE 15
2 TACROLIMUS 15
3 MIDAZOLAM 14
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 14
5 TACROLIMUS OINTMENT 0.1% 14
6 CLOPIDOGREL BISULFATE 13
7 LINEZOLID 13
8 CLOPIDOGREL 12
9 TICAGRELOR 12
See all common drugs associated with DIABETIC MACROANGIOPATHY

DIABETIC MACROANGIOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BASILIXIMAB 15 0.0013
1 HYALURONIC ACID 1 0.0009
2 PIPERACILLIN AND TAZOBACTAM 9 0.0007
3 TENECTEPLASE 1 0.0006
4 MIDAZOLAM HYDROCHLORIDE 15 0.0005
5 NOREPINEPHRINE BITARTRATE 8 0.0005
6 PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 9 0.0005
7 LINEZOLID 13 0.0004
8 MYCOPHENILIC ACID 8 0.0004
9 TICAGRELOR 12 0.0004
See all drugs enriched for association with DIABETIC MACROANGIOPATHY